Original Research
Accepted on 15 Aug 2025
European experience of patients with HER2-positive advanced/metastatic breast cancer accessing trastuzumab deruxtecan through a named patient program: the EUROPA T-DXd study
in Breast Cancer
Original Research
Accepted on 15 Aug 2025
in Breast Cancer
Original Research
Accepted on 15 Aug 2025
in Sport Psychology
Original Research
Accepted on 15 Aug 2025
in Bioengineering
Case Report
Accepted on 15 Aug 2025
in Surgical Oncology
Original Research
Accepted on 15 Aug 2025
in Cancer Metabolism
Original Research
Accepted on 15 Aug 2025
in Biophotonics
Review
Accepted on 15 Aug 2025
in Thoracic Surgery
Original Research
Accepted on 15 Aug 2025
in Industrial Biotechnology
Original Research
Accepted on 15 Aug 2025
in Abdominal Transplantation
Original Research
Accepted on 15 Aug 2025
in Molecular and Cellular Pathology
Original Research
Accepted on 15 Aug 2025
in Health Psychology
Original Research
Accepted on 15 Aug 2025
in Gastroenterology
Original Research
Accepted on 15 Aug 2025
in Experimental Endocrinology
Original Research
Accepted on 15 Aug 2025
in Reproduction
Systematic Review
Accepted on 15 Aug 2025
in Reproduction
Systematic Review
Accepted on 15 Aug 2025
in Pediatric Endocrinology